Funder: Breakthrough T1D
Due Dates (Anticipated): October 2026 (Full proposal, projected)
Funding Amounts: Up to $200,000 (including 10% indirects) for 1 year; not renewable.
Summary: Provides seed funding for highly innovative, high-risk/high-reward research with the potential to transform understanding or treatment of type 1 diabetes.